Toxicity of a polymer-graphene oxide composite against bacterial planktonic cells, biofilms, and mammalian cellsElectronic supplementary information (ESI) available: Bacterial OD600 absorbance growth curves, representative LIVE/DEAD images and percent of inactive cells after treatment with the most toxic concentrations of nanomaterials, bacterial OD540 nm biofilm absorbance, percent toxicity on the ITO-modified surfaces, additional TEM/SEM images of the nanomaterials and B. subtilis, NIH 3T3 fib

• Main Authors: Mejías Carpio, Isis E, Santos, Catherine M, Wei, Xin, Rodrigues, Debora F
• Format: Journal Article
• Language: English
• Published: 12.07.2012
• ISSN: 2040-3364; 2040-3372
• DOI: 10.1039/c2nr30774j

It is critical to develop highly effective antimicrobial agents that are not harmful to humans and do not present adverse effects on the environment. Although antimicrobial studies of graphene-based nanomaterials are still quite limited, some researchers have paid particular attention to such nanocomposites as promising candidates for the next generation of antimicrobial agents. The polyvinyl- N -carbazole (PVK)-graphene oxide (GO) nanocomposite (PVK-GO), which contains only 3 wt% of GO well-dispersed in a 97 wt% PVK matrix, presents excellent antibacterial properties without significant cytotoxicity to mammalian cells. The high polymer content in this nanocomposite makes future large-scale material manufacturing possible in a high-yield process of adiabatic bulk polymerization. In this study, the toxicity of PVK-GO was assessed with planktonic microbial cells, biofilms, and NIH 3T3 fibroblast cells. The antibacterial effects were evaluated against two Gram-negative bacteria: Escherichia coli and Cupriavidus metallidurans ; and two Gram-positive bacteria: Bacillus subtilis and Rhodococcus opacus. The results show that the PVK-GO nanocomposite presents higher antimicrobial effects than the pristine GO. The effectiveness of the PVK-GO in solution was demonstrated as the nanocomposite "encapsulated" the bacterial cells, which led to reduced microbial metabolic activity and cell death. The fact that the PVK-GO did not present significant cytotoxicity to fibroblast cells offers a great opportunity for potential applications in important biomedical and industrial fields. Industrial and biomedical applications of a PVK-GO nanocomposite with antibacterial properties and non-significant cytotoxicity to mammalian cells.